Akebia Therapeutics (AKBA) Stock Research

Friday

Leerink gets more bearish on Akebia, downgrades shares

AKBA

Aug 7, 6:16 AM

Wednesday

Akebia reports Q2 EPS (3c), consensus (3c)

AKBA

Aug 5, 4:48 PM

Over a week ago

Akebia initiates ebribafusp basket trial

AKBA

Aug 3, 8:19 AM

Akebia announces VOICE trial met predefined stopping criteria

AKBA

Jun 30, 8:25 AM

Akebia announces new Vafseo patent

AKBA

Jun 10, 8:25 AM

Akebia reports Q1 EPS (3c), consensus 0c

AKBA

May 7, 7:26 AM

Akebia doses first participants in AKB-9090 trial

AKBA

Apr 13, 8:48 AM

Akebia reports Q4 EPS (5c), consensus (4c)

AKBA

Feb 26, 7:07 AM

Akebia price target lowered by $1 at BTIG, here's why

AKBA

Feb 25, 7:18 AM

Akebia price target lowered by $2 at Piper Sandler, here's why

AKBA

Feb 6, 6:51 AM

Akebia announces corporate updates, 2026 pipeline outlook

AKBA

Jan 12, 8:45 AM

Akebia announces first patient dosed in Phase 2 trial of praliciguat

AKBA

Jan 6, 8:15 AM

Akebia Therapeutics announces establishment of rare kidney disease pipeline

Dec 1, 7:15 AM

Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront

Dec 1, 7:05 AM

What You Missed On Wall Street On Monday

+27

Nov 10, 4:30 PM

Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension

+29

Nov 10, 12:02 PM

Akebia reports Q3 EPS 0c vs (10c) last year

AKBA

Nov 10, 7:07 AM

Akebia price target lowered by $2 at H.C. Wainwright, here's why

AKBA

Oct 30, 6:06 AM

Akebia says not in alignment with FDA on path forward for VALOR clinical trial

AKBA

Oct 28, 4:42 PM

Akebia, IRC announce broad availability of Vafseo across IRC dialysis clinics

AKBA

Aug 21, 8:15 AM

No more stories